GLP-1 receptor agonists, the class of drugs that includes semaglutide and similar medications now widely prescribed for diabetes and weight loss, have been linked in recent analyses to a lower rate of ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...